Independent European data on CP-GEP model in Stratifying Melanoma Patients for Long Term Survival [Yahoo! Finance]
Quest Diagnostics Incorporated (DGX)
Last quest diagnostics incorporated earnings: 4/22 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
ir.questdiagnostics.com
Company Research
Source: Yahoo! Finance
European Association for Dermato-Oncology congress, April 4-6, 2024 . These publications show Merlin test's (CP-GEP model) ability to identify early-stage cutaneous melanoma patients at high risk for relapse. The first is a study led by researchers from Denmark, Weitemeyer, et al, that examined over 400 patients who underwent a sentinel lymph node biopsy (SLNB) between 2010 and 2015 . All the biopsies were defined as negative for metastasis. The CP-GEP model was applied on the prospectively collected, archived tumor specimens and its outcome correlated with the patients' clinical data for 5 years following diagnosis (for both recurrence free survival and overall survival). The findings indicate that the model effectively stratifies node-negative patients in two groups: patients at low – and high risk for disease progression. In the high-risk group, 17.2% experienced a recurrence of the disease in the 5-year following diagnosis compared to 8% in the low-risk group. While a nodal as
Show less
Read more
Impact Snapshot
Event Time:
DGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DGX alerts
High impacting Quest Diagnostics Incorporated news events
Weekly update
A roundup of the hottest topics
DGX
News
- FDA brings lab tests under federal oversight in bid to improve accuracy and safety [MSNBC.com]MSNBC.com
- FDA moves to bring multibillion-dollar medical test industry under full government scrutiny [Fortune]Fortune
- FDA brings lab tests under federal oversight in bid to improve accuracy and safety [Yahoo! Finance]Yahoo! Finance
- Variantyx raises $36m to commercialise genomic diagnostics [Yahoo! Finance]Yahoo! Finance
- Quest Diagnostics Incorporated Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions [Yahoo! Finance]Yahoo! Finance
DGX
Earnings
- 4/23/24 - Beat
DGX
Sec Filings
- 4/29/24 - Form 144
- 4/26/24 - Form 4
- 4/26/24 - Form 4
- DGX's page on the SEC website